Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma - No Study Results Posted

Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma (GOTEL-FL1LC)

This study is currently recruiting participants.

Study NCT00722930 Information provided by Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas

First Received: July 25, 2008 No Changes Posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	April 2013
Estimated Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)